The largest database of trusted experimental protocols
> Chemicals & Drugs > Organic Chemical > Mecamylamine

Mecamylamine

Mecamylamine is a nicotinic acetylcholine receptor antagonist used as a ganglionic blocker and antihypertensive agent.
It is also being investigated for its potential therapeutic effects in neurological and psychiatric disorders, such as Tourette's syndrome, Parkinson's disease, and drug addiction.
PubCompare.ai's AI-driven platform can help researchers optimize their Mecamylamine research protocols by locating the best protocols from literature, pre-prints, and patents using advanced AI comparisons.
This can identify the most effective products and techniques to accelerate Mecamylamine studies and streamline the research workflow.

Most cited protocols related to «Mecamylamine»

Transverse hippocampal slices were obtained from P21–P30 Chrna2-cre/R26tom and wild type littermate mice, Chrna2-cre/Viaatlx mice, and 1–2 month-old hChR2 carrying mice of either sex (see Virus injection) as previously described and according to the rules of Animal Experimentation of the Uppsala University. Slices were maintained in artificial CSF (in mmol: 124 NaCl, 3.5 KCl, 1.25 NaH2PO4, 1.5 MgCl2, 1.5 CaCl2, 24 NaHCO3, 10 glucose), constantly bubbled with 95% O2 and 5% CO2. Borosilicate glass electrodes (resistance = 4–8MΩ for somatic recordings; 12–18MΩ for dendritic recordings) were filled with either K-gluconate or CsCl-based internal solution49 (link). Current/voltage clamp recordings were obtained from using either a Dagan BVC700 (Dagan), Axopatch 200B or a Multiclamp 700B (Molecular Devices) amplifiers; data was acquired by National Instruments DAQ cards and winWCP (Dr John Dempster, Strathclyde University, UK). No differences between firing and passive membrane properties and morphology of CA1 OLM cells were found between Chrna2-cre and WT littermates (n=153 cells); therefore, data is presented only from mice carrying Cre recombinase. Postsynaptic currents were obtained in voltage clamp at a holding potential of −60mV using a CsCl-based internal solution (Cl reversal potential = 0mV).
Extracellular field EPSP (fEPSP) recordings (LTP experiments) were obtained by placing a concentric stimulation electrode (FHC) either at SR or SLM (for SC or TA stimulation, respectively) as previously described14 (link). A borosilicate glass pipette (4–8MΩ) filled with ACSF was used to record SC or TA fEPSPs at the CA1 region 200–400 µm away from the stimulation electrode. Stimulation strength was adjusted to obtain 50–60% of the maximum fEPSP amplitude followed by 20min recordings (200ms pulses delivered every 20s) to obtain a stable fEPSP baseline. Stimulus-response curves were obtained from fEPSPs slopes and synaptic potentiation was induced by weak theta burst stimulation (wTBS; two bursts of four pulses at 100 Hz spaced by 200 ms). The following drugs were bath applied to brain slices: tetrodotoxin (1µM), methyllycaconitine citrate (MLA, Tocris, 10nM), 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX, Sigma, 10uM), d-(−)-2-Amino-5-phosphonopentanoic acid (dAP5, Sigma, 30µM), picrotoxin (PTX, Sigma, 10uM), mecamylamine hydrochloride (MEC, Sigma, 25µM), and (−)-Nicotine ditartrate (Nic, Tocris, 1µM).
Publication 2012
6-Cyano-7-nitroquinoxaline-2,3-dione Amino Acids Bath Bicarbonate, Sodium Brain Cells cesium chloride Citrates Cre recombinase Dagan Debility Dendrites Diploid Cell Excitatory Postsynaptic Potentials gluconate Glucose Magnesium Chloride Mecamylamine Medical Devices methyllycaconitine Mus Nicotine Pharmaceutical Preparations Picrotoxin Postsynaptic Current Pulses Sodium Chloride SR-AT Tetrodotoxin Tissue, Membrane Virus
We recorded extracellular neuronal activity from three hemispheres in three male macaque monkeys (Macaca mulatta), whilst applying ACh, scopolamine or mecamylamine iontophoretically on selected trials. Animals were implanted with a custom made head-holding device and recording chambers made of Tecapeek GF for compatibility in functional magnetic resonance imaging settings. Surgical procedures were performed under aseptic conditions and general anaesthesia. Experiments and surgeries were performed in accordance with the European Communities Council Directive 1986 (86/609/EEC), the National Institutes of Health (Guidelines for Care and Use of Animals for Experimental Procedures), the Society for Neurosciences Policies on the Use of Animals and Humans in Neuroscience Research, and the UK Animals Scientific Procedures Act.
The monkey’s task was to detect a small change in luminance at a cued (attended) location, while ignoring a change that occurred at a non-cued location and fixating a central fixation spot throughout the trial. After a fixation-only period, two identical stimuli were presented (test stimuli): one centred on the receptive field and the other at the same eccentricity in the opposite hemi-field. After 500–800 ms (randomized in 1 ms steps) a patch appeared at the centre of one of the bars. If presented in the cued location the monkey had to release the touch bar within 500 ms to receive a juice reward. If presented in the un-cued location the monkey had to continue to hold the touch bar and maintain fixation until target appearance. This occurred 1,000–1,300 ms (randomized in 1 ms steps) after the distracter appeared. Thus, we recorded activity when animals attended to the receptive field of the neuron under study and when they attended away from it. We then compared activity levels for these attentional conditions with and without drug application.
For all further information about the paradigm, the neuronal recordings, iontophoresis and data analysis, see Supplementary Methods.
Publication 2008
Animals Asepsis Attention General Anesthesia Head Homo sapiens Iontophoresis Macaca Macaca mulatta Males Mecamylamine Medical Devices Monkeys Neurons Operative Surgical Procedures Pharmaceutical Preparations Scopolamine Touch

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2019
Drug Interactions Ethanol Homo sapiens Mecamylamine Nicotine Nicotine Bitartrate Obstetric Delivery Propylene Glycol Rattus Saline Solution Subcutaneous Injections

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2009
Cannula Cranium Diploid Cell Immunoglobulins Mecamylamine Nicotine Nicotine Dependence Nicotinic Antagonists Obstetric Delivery Osmosis Pharmaceutical Preparations Rattus norvegicus Saline Solution
Mice were instrumented with telemetry transmitters to record arterial pressure and heart rate (PA-C20, Data Sciences, St. Paul, MN, U.S.A.). Transmitters were implanted as previously described 14 (link). Following 1 week of recovery from surgery, baseline data were recorded for 7 days prior to implantation of micro-osmotic pumps (ALZET®, 1007D, 0.5μL/hour) to infuse leptin (10 μg/day) 15 (link), 16 (link) subcutaneously. In a second set of mice, similar micro-osmotic pumps were implanted subcutaneously, in the PTP1B KO mice only, to determine the cardiovascular consequences of insulin treatment (2Units/kg/ day)17 (link). To avoid any drop in blood glucose, mice were supplemented with a 10% glucose solution in drinking water 18 (link). A different set of mice was used to determine the effects of a hypocaloric diet, mimicking leptin effects, on blood pressure. After 7 days of baseline blood pressure recording, mice were submitted to a 20% food restriction calculated from the average food intake during the baseline data collection period. Data were recorded throughout the infusion period. Mice were then sacrificed and tissues and plasma were collected for later analysis. In a different set of mice, the carotid artery and jugular vein were catheterized under isoflurane anesthesia (1.5%) for the measurement of mean arterial pressure (MAP) and drug delivery, respectively. To eliminate endogenous sympathetic vasomotor tone and baroreceptor-reflex-mediated responses, animals were given the ganglionic blocker mecamylamine (2 mg/kg, IV.). Effective blockade was confirmed by the absence of reflex bradycardia after constrictor administration. Changes in MAP were determined after injection of randomized boluses of PE (0.01 to 1 mg/kg) and expressed as percent of the baseline blood pressure 19 (link).
Publication 2009
Anesthesia Animals Baroreflex Blood Glucose Blood Pressure Cardiovascular System Common Carotid Artery Diet Drug Delivery Systems Eating Food Ganglionic Blockers Glucose Insulin Isoflurane Jugular Vein Leptin Mecamylamine Mus Operative Surgical Procedures Osmosis Ovum Implantation Plasma PTPN1 protein, human Rate, Heart Telemetry Tissues

Most recents protocols related to «Mecamylamine»

All mice were handled for 1 h per day for two weeks prior to the behavioral tests. The behavioral session was conducted in a fear conditioning box (46001, UGO BASILE S.r.l, Italy). Freezing was defined as a complete absence of movement, except for respiration. Scoring of the freezing response duration was started after one second of sustained freezing behavior [34 (link)]. The freezing was measured using the Anymaze (version 6.0, Stoelting) software based on a threshold of change in video image pixels. The mice were delivered with 10 kHz and 1 kHz tones and the percentage of freezing time was averaged for the tone each day.
The changing index of freezing was calculated using the equation: Thechangingindex=TlightonfreezingTlightofffreezing/Tlightonfreezing+Tlightofffreezing.
The discrimination index of fear memory was calculated using the equation: Thediscriminationindex=T10kHzfreezingT1kHzfreezing/T10kHzfreezing+T1kHzfreezing.
At the encoding stage (day 1), after 5 min of habituation in context A, the mice received 5 pairings of auditory tone (70 dB SPL 10 kHz or 1 kHz pure tone, 20 s duration) with electric foot shocks (1 mA, 2 s duration, and overlapped with the last 2 s of tone). The time interval between each trial was 70 s. In Fig. 1E, F, and S1C, 10 min before the test, 0.5 µl of pharmacological agent was administered simultaneously bilaterally at a rate of 0.125 µl every 10 s by cannula. The mice were administered either saline, mecamylamine (MCM, 10 µM, 20 µM Aladdin, 826-39-1), or atropine alone (10 µM, 20 µM Aladdin, 5908-99-6). In Fig. 2, each tone is accompanied by optogenetic inhibition or activation. In Fig. 2G, 30 min before the test, mice were intraperitoneally injected with saline and nicotine (10 µM, Sigma Aldrich), and each tone is accompanied by optogenetic inhibition.
At test 0 (day 2), to label tone-responsive ACx neurons, the mice were delivered three times of 10 kHz tone or three times 1 kHz tone.
At test 1a or test 1b (day 2 or day 3), the mice were tested for freezing behavior in response to tests 1a (new fear-unpaired 1 kHz or 10 kHz tone) and 1b (fear-paired 10 kHz or 1 kHz) with a time interval of 2 h in different contexts B and C. The mice were delivered three (Figs. 1, 2, 4, 5 and Figs. S1, 2G, H, 4) or four (Fig. 3, S2E, F) representations of both 10 kHz and 1 kHz tones. In groups with four representations of tones, the first and third tones were accompanied by optogenetic activation or inhibition. In Fig. S2A–C, the mice were only given 10 times optogenetic activations. For test 1, each group of mice was randomly assigned and then equally received 1 kHz or 10 kHz tone in different contexts B and C, and after 90 min, the mice were carefully perfused.
All contexts were different in shape, background, and floor texture.
Full text: Click here
Publication 2023
Atropine Cannula Discrimination, Psychology Electricity Fear Fear of disease Foot Hearing Mecamylamine Memory Mice, House Movement Neurons Nicotine Optogenetics Psychological Inhibition Respiration Saline Solution Shock
The experimenter was blinded to genotype during both recordings and subsequent data analysis. L3 larvae were dissected under extracellular saline as described59 (link) with the only modification being a red filter applied to both the dissecting light and compound microscope to minimize DmCRY degradation before and during recordings. Thick-walled borosilicate glass electrodes (GC100F-10; Harvard Apparatus) were fire-polished to resistances of 10–15 MΩ. Recordings were made using the Multiclamp 700B amplifier controlled by pCLAMP (v.10.4) and the Digidata 1440A analogue-to-digital converter (Molecular Devices). Only cells with an input resistance of ≥500 MΩ were used. Traces were filtered at 10 kHz and sampled at 20 kHz. The extracellular saline solution contained the following: 135 mM NaCl, 5 mM KCl, 4 mM MgCl2.6H2O, 2 mM CaCl2.2H2O, 5 mM TES and 36 mM sucrose, pH 7.15. The intracellular patch solution contained the following (in mM): 140 mM potassium-d-gluconate, 2 mM MgCl2.6H2O, 2 mM EGTA, 5 mM KCl and 20 mM HEPES, pH 7.4. KCl and CaCl2 were from Thermo Fisher Scientific; sucrose was from BDH; all of the remaining chemicals were from Sigma-Aldrich. Mecamylamine (1 mM) was applied to all preparations to isolate the aCC motoneurons from excitatory cholinergic synaptic input. For recordings supplemented with additional FAD or riboflavin (Sigma-Aldrich), dilutions were made up in intracellular saline and kept in the dark.
Full text: Click here
Publication 2023
Cells Cholinergic Agents Egtazic Acid Genotype gluconate HEPES Larva Light Light Microscopy Magnesium Chloride Mecamylamine Medical Devices Motor Neurons Potassium Protoplasm Riboflavin Saline Solution Sodium Chloride Sucrose Technique, Dilution
The effects of iROE on mechanical hyperalgesia caused by plantar incision were further investigated to ascertain whether they were involved in α1 and α2 adrenergic, cholinergic (nicotinic and muscarinic), and opioid receptors. Forty-two rats were randomly allocated to seven groups (n = six rats per group), including one iROE group that served as a control and the other six groups that included rats that were given iROE and study drugs (yohimbine 2 mg/kg, dexmedetomidine 50 μg/kg, prazosin 1 mg/kg, atropine 5 mg/kg, mecamylamine 1 mg/kg, and naloxone 5 mg/kg). Two hours after the plantar incisions, normal saline or study drugs were administered intraperitoneally. After 10 min, 300 mg/kg iROE was administered intraperitoneally. Previous study suggested the application of drugs to investigate the possible involvement of the aforementioned receptor systems [9 (link),15 (link),16 (link),17 (link),18 (link)]. All study drugs were provided by Sigma-Aldrich.
Full text: Click here
Publication 2023
Adrenergic Agents Atropine Cholinergic Agents Dexmedetomidine Mecamylamine Mechanical Allodynia Muscarinic Agents Naloxone Nicotine Normal Saline Opioid Receptor Pharmaceutical Preparations Prazosin Rattus norvegicus Yohimbine
Primary cortical astrocytes were trypsinized from established cultures and sub-cultured in 24 well plates (250,000 cells/mL) for synaptogenesis and electrophysiology experiments, or on the underside of 0.4 μm mesh 6-well plate inserts for protein expression experiments. Wells and inserts were coated with 40 μg/mL PDL. Forty-eight hours prior to co-culture with neurons, astrocytes were serum deprived (DMEM + 0.1% bovine serum albumin and P/S) for 24 hours, and then treated with or without carbachol (0.01, 0.10, 1 mM) for an additional 24 hours. Astrocytes were washed with PBS and incubated in serum-free medium for three hours prior to co-culture with neurons. In some experiments, 30 minutes prior to the addition of carbachol, astrocytes were treated with 10 μM of the acetylcholine receptor antagonists, mecamylamine, gallamine, or 4-DAMP. After treatment washout and medium conditioning, primary hippocampal neurons (12–13 DIC), grown on glass coverslips were inverted over the pre-treated astrocyte monolayer for immunocytochemistry or electrophysiology experiments. Neurons were never in direct contact with astrocytes, nor were they exposed to astrocyte treatments. For Western blot experiments, astrocytes plated on the underside of porous inserts and their medium were transferred to 6-well plates containing primary hippocampal neurons.
To block TSP1 signaling in neurons, after astrocyte carbachol pre-treatment and washout, neurons and astrocytes were pre-treated for half hour with gabapentin (15 or 30 μM) prior to co-culturing; gabapentin remained throughout the co-culture incubation. For all co-culture experiments, astrocytes and neurons were co-incubated for 24 hours.
Full text: Click here
Publication Preprint 2023
4-diphenylacetoxy-1,1-dimethylpiperidinium Astrocytes Carbachol Cardiac Arrest Cells Cholinergic Antagonists Coculture Techniques Cortex, Cerebral Gabapentin Gallamine Immunocytochemistry Mecamylamine Neurons Proteins Serum Serum Albumin, Bovine thrombospondin-1, human Western Blot
Neurobasal-A medium, Dulbecco’s Modified Eagle’s Medium, B-27 Supplement, GlutaMax, fungizone and gentamicin were purchased from Gibco. Poly-l-ornithine hydrobromide (PLO), poly-d-lysine (PDL), cytosine d-arabinoside (ARAC), carbamylcholine chloride (carbachol), mecamylamine hydrochloride, gallamine triethiodide, and gabapentin were purchased from Sigma-Aldrich. 1,1 Dimethyl-4-diphenylacetoxypiperidinium iodide (4-DAMP) was purchased from Tocris Biosciences. Rabbit monocolonal antibody to synaptophysin (ab52636) and rabbit polyclonal antibody to synaptotagmin (ab10104) were purchased from Abcam. The mouse monoclonal antibody to PSD95 (7E3–1B8) used in immunocytochemistry was purchased from Thermo Scientific. The mouse monoclonal antibodies PSD95 (Clone K28/43) for immunoblotting, and NR2B (Clone N59–36) were developed by and obtained from the UC Davis/NIH Neuromab facility. The goat anti-mouse TSP1 antibody (A6.1) was obtained from EMD/Millipore/Calbiochem. Donkey anti-rabbit Alexa Fluor 488 and donkey anti-mouse Alexa 555 were obtained from Invitrogen. Anti-mouse horseradish peroxidase (HRP) was purchased from BD Biosciences and anti-rabbit HRP was obtained from Cell Signaling Technology. Human TSP1 was obtained from Haematologic Technologies, Inc.
Full text: Click here
Publication Preprint 2023
4-diphenylacetoxy-1,1-dimethylpiperidinium alexa fluor 488 Antibodies, Anti-Idiotypic Carbachol Carbamoylcholine Chlorides Clone Cells Cytosine Dietary Supplements Eagle Equus asinus Fungizone Gabapentin Gentamicin Goat GRIN2B protein, human Homo sapiens Horseradish Peroxidase Immunocytochemistry Immunoglobulins Iodides Lysine Mecamylamine Monoclonal Antibodies Mus Poly A polyornithine Rabbits Synaptophysin Synaptotagmins Thrombospondin 1 Triethiodide, Gallamine

Top products related to «Mecamylamine»

Sourced in United States, United Kingdom, Germany, Japan
Mecamylamine is a chemical compound that functions as a nicotinic acetylcholine receptor antagonist. It is a laboratory product used in various research applications.
Sourced in United States, Germany, United Kingdom
Mecamylamine hydrochloride is a chemical compound used as a laboratory reagent. It is a nicotinic acetylcholine receptor antagonist. The core function of this product is to serve as a research tool for studying nicotinic receptor-mediated processes in various in vitro and in vivo experimental models.
Sourced in United States, Germany, United Kingdom, France, Sao Tome and Principe, Macao, Japan, Australia, Canada, Italy
Nicotine is a chemical compound found in the tobacco plant. It is a colorless, volatile, and alkaline liquid with a distinctive odor. Nicotine is commonly used in laboratory settings for research and analysis purposes.
Sourced in United Kingdom, United States
Mecamylamine is a laboratory reagent used in scientific research. It is a nicotinic acetylcholine receptor antagonist that can be used to study the effects of nicotine and related compounds on cellular and physiological processes. The core function of Mecamylamine is to block the activity of nicotinic acetylcholine receptors, which can provide insights into the role of these receptors in various biological systems.
Sourced in United States, Canada, Sao Tome and Principe
Nicotine hydrogen tartrate salt is a chemical compound that is used as a laboratory reagent. It is a crystalline solid and is soluble in water and various organic solvents. The compound is commonly used in scientific research and development applications.
Sourced in United States, Sao Tome and Principe, United Kingdom
Nicotine hydrogen tartrate is a chemical compound used in various laboratory applications. It serves as a precursor for the synthesis of nicotine and other related compounds. The compound is a white, crystalline powder with a characteristic odor. It is soluble in water and certain organic solvents. Nicotine hydrogen tartrate is primarily utilized in research and development settings to facilitate the study and production of nicotine-based products.
Sourced in United States, United Kingdom, Germany, France, Sao Tome and Principe, Canada, Israel, Australia, Italy, Japan
Picrotoxin is a chemical compound that acts as a GABA antagonist. It is primarily used in scientific research as a tool to study the function of GABA receptors.
Sourced in United Kingdom, France, United States
Dihydro-β-erythroidine hydrobromide (DHβE) is a pharmacological compound used in research applications. It functions as a nicotinic acetylcholine receptor antagonist. The core purpose of this product is to facilitate studies and experiments involving the modulation of nicotinic acetylcholine receptor activity.
Sourced in United States, Germany, United Kingdom, China, Italy, Sao Tome and Principe, France, Macao, India, Canada, Switzerland, Japan, Australia, Spain, Poland, Belgium, Brazil, Czechia, Portugal, Austria, Denmark, Israel, Sweden, Ireland, Hungary, Mexico, Netherlands, Singapore, Indonesia, Slovakia, Cameroon, Norway, Thailand, Chile, Finland, Malaysia, Latvia, New Zealand, Hong Kong, Pakistan, Uruguay, Bangladesh
DMSO is a versatile organic solvent commonly used in laboratory settings. It has a high boiling point, low viscosity, and the ability to dissolve a wide range of polar and non-polar compounds. DMSO's core function is as a solvent, allowing for the effective dissolution and handling of various chemical substances during research and experimentation.
Sourced in United States
Mecamylamine HCl is a chemical compound used as a laboratory reagent. It is a nicotinic acetylcholine receptor antagonist. Mecamylamine HCl is commonly used in research applications, but its specific functions and intended uses should not be extrapolated or interpreted beyond its core purpose as a laboratory tool.

More about "Mecamylamine"

Mecamylamine is a powerful nicotinic acetylcholine receptor (nAChR) antagonist that has been studied extensively for its potential therapeutic applications in a variety of neurological and psychiatric disorders.
As a ganglionic blocker and antihypertensive agent, mecamylamine is used to treat conditions like Tourette's syndrome, Parkinson's disease, and drug addiction.
The mecamylamine molecule is closely related to nicotine, another nAChR agonist, as well as the nicotine hydrogen tartrate salt and dihydro-β-erythroidine hydrobromide (DHβE), which are also nAChR antagonists.
Picrotoxin, a GABA-A receptor antagonist, is sometimes used in conjunction with mecamylamine to investigate the interplay between cholinergic and GABAergic systems.
Researchers can leverage PubCompare.ai's advanced AI-driven platform to optimize their mecamylamine research protocols.
By accessing the best protocols from literature, preprints, and patents, scientists can identify the most effective products and techniques to accelerate their mecamylamine studies and streamline their research workflow.
This can lead to faster discoveries and breakthroughs in the treatment of neurological and psychiatric disorders.
PubCompare.ai's intelligent tools, which can handle tasks like searching, comparing, and synthesizing research data, can be particularly useful for mecamylamine research.
Dimethyl sulfoxide (DMSO) is sometimes used as a solvent for mecamylamine hydrochloride, and PubCompare.ai can help researchers find the optimal protocols and techniques for working with these compounds.
By utilizing the insights and capabilities provided by PubCompare.ai, researchers can unlock new possibiliies in the field of mecamylamine research and drive progress in the treatment of complex neurological and psychiatric conditions.